引用本文:刘冬梅,秦 燕,韦丹燕,庞 俊.不同孕周高效抗反转录病毒治疗对HIV母婴阻断效果的比较[J].中国临床新医学,2016,9(9):770-772.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1385次   下载 1212 本文二维码信息
码上扫一扫!
分享到: 微信 更多
不同孕周高效抗反转录病毒治疗对HIV母婴阻断效果的比较
刘冬梅,秦 燕,韦丹燕,庞 俊
530023 广西,南宁市第四人民医院(广西艾滋病临床治疗中心)妇产科(刘冬梅,秦 燕,庞 俊);530222 南宁,广西中医药大学赛恩斯新医药学院实验教学中心(韦丹燕)
摘要:
[摘要] 目的 探讨不同孕周抗反转录病毒治疗对HIV母婴阻断的效果。方法 选择2012-01~2014-01就诊HIV感染孕妇,以AZT+3TC+LPV/r方案进行HIV母婴阻断,孕14周组30例,孕28周组30例。检测孕妇治疗前及预产期前一个月的CD4+ T淋巴细胞及病毒载量变化,观察婴儿出生情况及是否感染HIV(出生后18月龄进行HIV抗体检测)。结果 孕14周组孕妇治疗前及预产期前一个月CD4+ T淋巴细胞高于孕28周组,病毒载量低于孕28周组(P<0.05)。两组婴儿18月龄时HIV抗体阳性率差异均无统计学意义(P>0.05)。结论 采用相同高效抗反转录病毒治疗方案对孕14周、孕28周的HIV孕妇进行母婴阻断,婴儿结局相似,但孕14周组应用高效抗反转录病毒治疗比孕28周组在抑制病毒复制,减少病毒负荷量,降低病毒传播性的效果更为显著。
关键词:  高效抗反转录病毒治疗方案  艾滋病  母婴阻断
DOI:10.3969/j.issn.1674-3806.2016.09.03
分类号:R 714.251
基金项目:南宁市科学研究与技术开发计划项目(编号:20133171);广西科学研究与技术开发计划项目(编号:桂科攻1355005-1-3)
The effect of highly active antiretroviral therapy in women with different weeks of pregnancy(HAART) on preventing of HIV
LIU Dong-mei, QIN Yan, WEI Dan-yan, et al.
Department of Obstetrics and Gynecology, the Fourth People′s Hospital of Nanning, Guangxi 530023,China
Abstract:
[Abstract] Objective To explore the effect of highly active antiretroviral therapy on blocking mother-to-infant transmission of HIV in women with different weeks of pregnancy(HAART).Methods Sixty pregnant women infected with HIV were divided into the 14-week-pregnant group(n=30) and the 28-week-pregnant group(n=30). Both of the two groups received AZT+3TC+LPV/r from January 2012 to January 2014 to block mother-to-infant transmission of HIV. The changes of CD4+ T lymphocytes and virus load were tested before the treatment and one month before due dates. The growth and development of the babies at birth were observed. and their HIV antibodies were detected when they were 18 months old.Results The CD4+ T lymphocytes were significantly higher and the virus load was lower in the 14-week-pregnant women than those in the 28-week-pregnant women before the treatment and one month before their due dates(P<0.05). There were no significant differences between the two groups in the conditions of the babies at birth including premature delivery, low birth weight, suffocating, and the positive rate of HIV antibody(P>0.05).Conclusion A similar outcome is showed in the babies of 14-week-pregnant women and 28-week-pregnant women, however less replication of virus and lower virus load are present in the babies of 14-week-pregnant women.
Key words:  Highly active antiretroviral therapy  Acquired immune deficiency syndrome(AIDS)  Preventing mother-to-infant transmission